Let's look at today's after-hours reality. $TNGX reports stellar 92% pancreatic cancer trial data and immediately drops a $500M dilutive public offering. In other news, $MPAA surges +36.92% on year-end earnings, and $APLD climbs +12.44% on a massive new AI lease.
But before chasing, check the historical data. Across 2,881 instances of catalyst-driven gaps above 30%, stocks like $TNGX close the day in the red 65% of the time. The market is structured to reward your patience, not your excitement.
Then close the laptop and journal the day.